ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2024

News provided by

Feb 05, 2024, 09:24 ET

Zinzino group revenue increased with a total of 15%, compared with the previous year.

GOTHENBURG, Sweden, Feb. 5, 2024 /PRNewswire/ -- The revenue in January for Zinzino's sales markets increased by 17% and amounted to SEK 140.2 (120.3) million. Faun Pharma's external sales decreased by 11% and amounted to SEK 8.1 (9.1) million. Overall, the Group increased revenues by 15% to SEK 148.3 (129.4) million compared with the previous year.

Revenues were distributed as follows:

Regions, mSEK	24-Jan	23-Jan	Change
The Nordics	22.6	23.4	-3 %
Central Europe	41,0	28.5	44 %
East Europe	31.8	32.8	-3 %
South & West Europe	21.8	15.9	37 %
The Baltics	8,0	7.4	8 %
North America	10.1	6.3	60 %
Asia-Pacific	3.9	4.6	-15 %
Africa	1,0	1.4	-29 %
Zinzino	140.2	120.3	17 %
Faun Pharma	8.1	9.1	-11 %
Zinzino Group	148.3	129.4	15 %

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa